Moderate riskFDA DeviceClass II

RayStation planning software recalled for possible dose loss

RaySearch Laboratories AB is recalling RayStation radiation therapy treatment planning software, versions 6.1.1.2 and 6.2.0.7. After a deformable registration that expands outward near the boundary of the original dose grid, the software may deform the dose, which could cause the clinically relevant dose to be lost. The notice reports no injuries.

From the FDA notice · Read the official notice ↗ · All Raysearch Laboratories recalls

What to do

  1. Stop using the affected versions, RayStation 6.1.1 (build 6.1.1.2) and RayStation 6 SP2 (build 6.2.0.7), for treatment planning until you contact RaySearch Laboratories.
  2. Check installed builds against UDIs 0735000201008220170529 (6.1.1.2) and 0735000201007520170630 (6.2.0.7), GTINs 07350002010082 and 07350002010075, and expiration dates 2022-06-01 and 2022-06-30.
  3. The notice doesn't say how to get a fix or replacement; contact RaySearch Laboratories AB directly.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
RayStation Systems: RayStation 6.1.1, RayStation 6 SP2. Model/Build Numbers: 6.1.1.2, 6.2.0.7. Software Radiation Therapy Treatment Planning System
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 9 products — see all of them.

Details

Units affected
3 units
Illnesses reported
None reported
Manufactured in
Eugeniavagen 18c, Stockholm, Sweden
Classification
Class II
Recall number
Z-0483-2027

In the FDA's words

Description
RayStation Systems: RayStation 6.1.1, RayStation 6 SP2. Model/Build Numbers: 6.1.1.2, 6.2.0.7. Software Radiation Therapy Treatment Planning System Potential for dose deformation after using a deformable registration that expands outwards near the boundary of the original dose grid, possibly causing the clinically relevant dose to be lost. Model/Build Numbers: 6.1.1.2, 6.2.0.7. UDI: 0735000201008220170529, 0735000201007520170630. GTIN: 07350002010082, 07350002010075. Serial Numbers: 6.1.1.2, 6.2.0.7. Software Revision: RayStation 6.1.1, RayStation 6 SP2. Expiration Date: 2022-06-01, 2022-06-30. Distribution: Worldwide - US Nationwide distribution. Affected quantity: 3 units
Hazard
Potential for dose deformation after using a deformable registration that expands outwards near the boundary of the original dose grid, possibly causing the clinically relevant dose to be lost.

9 products in this recall

RayStation software recalled for potential dose deformation

RaySearch Laboratories is recalling 9 product entries of its RayStation radiation therapy treatment planning software, from RayStation 6.1.1 through RayStation 2024A SP3, distributed nationwide in the US. The agency says a deformable registration that expands outward near the boundary of the original dose grid may deform the dose, possibly causing the clinically relevant dose to be lost. The notice reports no injuries.

The agency lists each product separately. Check every one you might have.

Related topics

OtherSoftwareMedical devicesSold nationwideMore from FDA Device